metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA) | |
metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA) | |
anti-PD-(L)1 | |
atezolizumab based treatment | |
atezolizumab alone | |
nivolumab based treatment | |
nivolumab alone | |
pembrolizumab based treatment | |
pembrolizumab alone |